The emerging clinical domain is chimera chains. Such engineered molecules integrate sections from multiple peptide families, enabling the development of novel pharmacological properties. The strategy provides the https://chimerapeptides819414.estate-blog.com/42255639/chimera-peptides-a-novel-therapeutic-frontier